FindTrial
Sign In

Effect of Individualized Alpha Peak Frequency Transcranial Alternating Current Stimulation for Persistent Delusions in Schizophrenia

Efficacy of Adjunctive Individualized Alpha Peak Frequency Transcranial Alternating Current Stimulation for Persistent Delusions in Schizophrenia - A Randomised Sham-Controlled Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059110
Enrollment
44
Registered
2023-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F209- Schizophrenia, unspecified

Interventions

Intervention1: Transcranial Alternating Current Stimulation: After RAndomization tACS is administered using standard equipment (Startstim-32, Neuroelectrics BE, Spa) with safety measures. It is a wear

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of schizophrenia using diagnostic criteria for research (DCR) of ICD-11 DCR (World Health Organization, 1993). 2. Psychotic symptoms rating scale (PSYRATS) – Delusion subscale score of more than 6. 3. Aged between years of 18-50 years of either sex. 4. Right-handed. 5. Patients giving written informed consent.

Exclusion criteria

Exclusion criteria: 1. Co-morbid neurological or any other psychiatric disorder. 2. History of substance abuse/dependence (except nicotine and caffeine). 3. History of epilepsy, significant head injury, or any neurosurgical procedure. 4. A patient who has received electroconvulsive therapy in the past month.

Design outcomes

Primary

MeasureTime frame
Changes in psyrats-D scores of persistent delusions after application of alpha tACS.Timepoint: After 5 days and after one month.—

Secondary

MeasureTime frame
Changes in alpha EEG (8- 12 Hz) spectral power and synchronization from baseline to posttreatment.Timepoint: After 5 days and after one month.—

Countries

India

Contacts

Public ContactDr Umesh S

Central Institute of Psychiatry

umesh.yes@hotmail.com9771702403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026